| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Jan 15, 2025 | Adaptimmune Therapeutics PLC | Chief Commercial Officer | Sell | 47.5 | -12,991 | -41.36% | ✗ | $7.5K |
| Jun 18, 2024 | Jun 18, 2024 | Adaptimmune Therapeutics PLC | Chief Commercial Officer | Sell | 46.3 | -24,531 | -39.05% | ✗ | $22.8K |
| Jan 31, 2023 | Jan 31, 2023 | Adaptimmune Therapeutics PLC | Chief Commercial Officer | Sell | 46.3 | -11,890 | -37.84% | ✗ | $22.2K |
| Aug 1, 2022 | Aug 1, 2022 | Adaptimmune Therapeutics PLC | Chief Commercial Officer | Sell | 46.3 | -21,040 | -37.66% | ✗ | $37.3K |